The Current Situation and Future Perspectives of Vaccines against Infectious Diseases in Children and Women—2nd Edition

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines against Tropical and other Infectious Diseases".

Deadline for manuscript submissions: 20 July 2025 | Viewed by 1792

Special Issue Editor


E-Mail Website
Guest Editor
Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
Interests: obstetrics and gynecology; perinatology; cytomegalovirus; rubella; mother-to-child infection
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Vaccination is crucial in reducing the prevalence of infectious diseases. Vaccinating children on time throughout their childhood is vital because it helps to provide immunity before they contract diseases. Moreover, all women should ensure that they are up-to-date with their vaccinations before becoming pregnant. It is important to keep women of a reproductive age up-to-date with immunizations, whether or not they are actively trying to conceive. Some vaccinations are strongly recommended, even for pregnant women. Several issues remain regarding vaccination against infectious diseases in children and women. Thus, we encourage the submission of articles and reviews on advances regarding the vaccination in children and women and articles on vaccination-related issues in these groups. Adding new information on these subjects may lead to a better understanding of vaccine-related disease prevention and the development of new vaccines against infectious diseases in children and women.

Prof. Dr. Masatoki Kaneko
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • children
  • mother-to-child transmission
  • pregnant women
  • women
  • vaccine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 258 KiB  
Article
Public Knowledge and Beliefs Regarding Pharmacy-Based Immunization in Poland—A Nationwide Cross-Sectional Study, 2024
by Iwona Wrześniewska-Wal, Justyna Grudziąż-Sękowska, Jarosław Pinkas and Mateusz Jankowski
Vaccines 2024, 12(8), 835; https://doi.org/10.3390/vaccines12080835 - 24 Jul 2024
Viewed by 1512
Abstract
Pharmacy vaccinations are a key public health intervention. This study aimed to assess society’s knowledge about pharmacy vaccinations in Poland. A cross-sectional study was conducted from 10 to 13 May 2024 among 1126 adults; the survey questionnaire contained 13 closed questions. Men (OR: [...] Read more.
Pharmacy vaccinations are a key public health intervention. This study aimed to assess society’s knowledge about pharmacy vaccinations in Poland. A cross-sectional study was conducted from 10 to 13 May 2024 among 1126 adults; the survey questionnaire contained 13 closed questions. Men (OR: 1.32; [1.02–1.70]; p < 0.05), and people aged 50–64 (OR: 1.55; [1.05–2.28]; p < 0.05), people with higher education (OR:1.74; [1.35–2.26]; p < 0.001), and people declaring trust in the pharmacist’s competencies (OR:3.95; [3.03–5.15]; p < 0.001) more often declared knowledge of vaccinations in pharmacies. Support for these services was declared by men (OR:1.74; [1.28–2.36]; p < 0.001) and people with higher education (OR:1.39; [1.02–1.89]; p < 0.05) and participants declaring trust in the pharmacist’s competences (OR:20.30; [14.65–28.11]; p < 0.001). Trust in pharmacists was important. People declaring trust in pharmacists were much more willing to get vaccinated against influenza (40.2%) and zoster (38.0%) at a pharmacy and declared that they would vaccinate their children against HPV at a pharmacy (38.8%) compared to people who did not trust the competences of pharmacists (p < 0.001). There was a significant difference in the case of influenza. People who trusted pharmacists were five times more likely to declare their willingness to get vaccinated against influenza (p < 0.001). Full article
Back to TopTop